Literature DB >> 11970983

NF-kappa B2 is required for optimal CD40-induced IL-12 production but dispensable for Th1 cell Differentiation.

Kendra Speirs1, Jorge Caamano, Michael H Goldschmidt, Christopher A Hunter, Phillip Scott.   

Abstract

NF-kappa B is a ubiquitously expressed transcription factor involved in the regulation of innate and adaptive immunity. As part of studies to define the role of various NF-kappa B family members in Th cell development and maintenance, we infected NF-kappa B2(-/-) and control mice with Leishmania major and followed disease progression. NF-kappa B2(-/-) mice on a normally resistant background develop chronic nonhealing lesions associated with uncontrolled parasite replication and a failure to develop an IFN-gamma response. We show that there are no intrinsic defects in Th cell differentiation in the absence of NF-kappa B2. Indeed, NF-kappa B2(-/-) T cells are able to develop a Th1 phenotype and protect recombination-activating gene(-/-) mice from progressive cutaneous leishmaniasis. We demonstrate instead that the susceptibility of NF-kappa B2(-/-) mice to L. major is the result of an IL-12 deficiency, and we provide evidence for a specific impairment in CD40-induced IL-12 production by macrophages lacking this transcription factor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11970983     DOI: 10.4049/jimmunol.168.9.4406

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection.

Authors:  C M Tato; C A Hunter
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

2.  c-Rel delivers a one-two punch in Th1 cell differentiation.

Authors:  Sung-Yun Pai; I-Cheng Ho
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

3.  The curative effect of fucoidan on visceral leishmaniasis is mediated by activation of MAP kinases through specific protein kinase C isoforms.

Authors:  Gunjan Sharma; Susanta Kar; Writoban Basu Ball; Kuntal Ghosh; Pijush K Das
Journal:  Cell Mol Immunol       Date:  2014-02-24       Impact factor: 11.530

4.  Construction and evaluation of rats' tolerogenic dendritic cells (DC) induced by NF-κB Decoy method.

Authors:  HongMei Jiang; YaLi Zhang; XiangFei Yin; HengGui Hu; XiaoLei Hu; Ying Fei; Yanyang Tu; Yongsheng Zhang
Journal:  Afr Health Sci       Date:  2014-09       Impact factor: 0.927

5.  Leishmania major amastigotes induce p50/c-Rel NF-kappa B transcription factor in human macrophages: involvement in cytokine synthesis.

Authors:  Lamia Guizani-Tabbane; Khadija Ben-Aissa; Meriam Belghith; Atfa Sassi; Koussay Dellagi
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 6.  CD40 and the immune response to parasitic infections.

Authors:  Carlos S Subauste
Journal:  Semin Immunol       Date:  2009-07-18       Impact factor: 11.130

7.  Modulation of T-cell costimulation as immunotherapy or immunochemotherapy in experimental visceral leishmaniasis.

Authors:  Henry W Murray; Cristina M Lu; Elaine B Brooks; Richard E Fichtl; Jennifer L DeVecchio; Frederick P Heinzel
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

8.  Susceptibility to tuberculosis: a locus on mouse chromosome 19 (Trl-4) regulates Mycobacterium tuberculosis replication in the lungs.

Authors:  Loukia-Maria Mitsos; Lon R Cardon; Lynn Ryan; Ronald LaCourse; Robert J North; Philippe Gros
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-09       Impact factor: 11.205

9.  Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper type 2 response.

Authors:  Ana Paula Galvão Da Silva; Jacqueline F Jacysyn; Ises De Almeida Abrahamsohn
Journal:  Immunology       Date:  2003-02       Impact factor: 7.397

10.  Classification and regression tree and spatial analyses reveal geographic heterogeneity in genome wide linkage study of Indian visceral leishmaniasis.

Authors:  Michaela Fakiola; Anshuman Mishra; Madhukar Rai; Shri Prakash Singh; Rebecca A O'Leary; Stephen Ball; Richard W Francis; Martin J Firth; Ben T Radford; E Nancy Miller; Shyam Sundar; Jenefer M Blackwell
Journal:  PLoS One       Date:  2010-12-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.